Molecular Formula | C19H12ClNO6S |
Molar Mass | 417.82 |
Density | 1.466±0.06 g/cm3(Predicted) |
Boling Point | 664.8±55.0 °C(Predicted) |
Solubility | DMSO: ≥ 47 mg/mL |
Storage Condition | -20℃ |
In vitro study | BTB06584 inhibits F1 Fo-ATPase activity in an if1-dependent manner, has no effect on ATP synthesis, and limits the ischemia-induced damage caused by mitochondrial F1 Fo-ATP synthase inversion. |
In vivo study | BTB06584 restores defective hemoglobin synthesis in zebrafish pintage (pnt) mutants without causing significant toxicity. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.393 ml | 11.967 ml | 23.934 ml |
5 mM | 0.479 ml | 2.393 ml | 4.787 ml |
10 mM | 0.239 ml | 1.197 ml | 2.393 ml |
5 mM | 0.048 ml | 0.239 ml | 0.479 ml |